Management of Myocardial Reperfusion Injury

Much has been written about myocardial reperfusion injury and the controversies surrounding its existence and clinical relevance in the past 20 to 30 years. Unfortunately, however, there is little published information that integrates research findings with the practical aspects of its management an...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Kaski, Juan Carlos (Επιμελητής έκδοσης), Hausenloy, Derek J. (Επιμελητής έκδοσης), Gersh, Bernard John (Επιμελητής έκδοσης), Yellon, Derek M. (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: London : Springer London : Imprint: Springer, 2012.
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
Πίνακας περιεχομένων:
  • Preface
  • Introduction
  • Myocardial reperfusion injury: The clinical importance and magnitude of the problem, JC Kaski and G Ambrosio
  • Section I. Myocardial reperfusion injury - Pathophysiology and molecular mechanisms
  • The "no-reflow phenomenon" leading to myocardial injury and dysfunction- Consequences of reperfusion injury: Pathophysiology and molecular basis, H M Piper
  • The coronary microcirculation expert’s view, A Pries
  • The pathologist’s view, R Virmani
  • The interventionist’s view
  • Commonly asked questions
  • Pathophysiology and molecular mechanisms - Established facts and future research avenues – An integrated view, D Yellon
  • Section II. Diagnosis
  • The electrocardiogram
  • Biomarkers
  • Angiography
  • Echocardiography
  • MRI
  • SPECT
  • PET, P Camici
  • Commonly asked questions
  • An integrated view on diagnostic strategies – Identifying salvageable myocardium
  • Diagnostic algorithms
  • Section III. Management – Currently available tools and future perspectives
  • An integrated view on management – What is effective and what is not
  • Discrepancies between results of treatment in experimental models and patients. Management algorithms, B Gersh
  • Catheter lab options, M Marzilli
  • Myocardial protection – Metabolic issues, WC Stanley
  • Myocardial protection – Preconditioning
  • New pharmacological options
  • Assessment of treatment efficacy
  • Commonly asked questions
  • Future perspectives, JC Kaski, D Yellon and B Gersch.